BSE · SUPHA

SUPHA PHARMACHEM LIMITED

Sector: Healthcare · ISIN: INE549S01036

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#3,925

of 5,004 stocks

🏆 New peak

▲ 471W

Peak #3,925 · 01 Oct 2026

A microcap name in Healthcare, SUPHA PHARMACHEM LIMITED trades at an undemanding earnings multiple, is growing revenue rapidly, and has a subdued return on equity. Ownership as of Dec 2025.

Market Cap

23.81 Cr

P/E Ratio

5.40

P/B Ratio

0.25

ROE

4.85%

ROCE

22.04%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q2 2025-26	Q1 2025-26	Q4 2024-25	Q3 2024-25
Revenue	111.06 Cr	113.37 Cr	264.32 Cr	38.15 Cr
Net Profit	8.62 Cr	4.65 Cr	-2.05 Cr	76.45 L
EPS	0.10	0.05	0.05	0.02
Operating Profit	10.62 Cr	5.35 Cr	19.29 L	1.94 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

1.13%

Public

98.87%

PUBLIC BREAKDOWN

FII

1.70%

Individuals

82.77%

As of 31 Dec 2025. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
15 Apr 2025	Other	Right Issue of Equity Shares
05 Jul 2024	Bonus	Bonus issue 3:1
23 Feb 2024	Split	Stock Split From Rs.5/- to Rs.1/-
01 Sep 2023	Split	Stock Split From Rs.10/- to Rs.5/-
28 Jul 2023	Bonus	Bonus issue 9:5

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs